China's proposed amendment of its state secrets law has alarmed foreign businesses; a U.S. Congressional committee will probe Sequoia over its China tech investments; and China will scrap its price cap on land sales to revive its property market
China approves the U.S. listing plans of VIE-structured company CheChe; Chinese IP court helps mediate dispute between Dyson and Dreame; and CSRC proposes rules to encourage companies to pay their dividends
China's cybersecurity laws are heavily enforced for businesses of all sizes; Chinese Gotion receives CFIUS approval to build an EV battery facility in Illinois; and Former SEC Chair proposes large public companies disclose their exposure to China
With the European Union's revised product safety rules coming into effect in December 2024, Chinese firms should take notice of major changes to the rules and how they can comply with them.
China meets executives of international firms in order to reassure them over data security regulations; CSRC seeks regulatory opinion for the frist time for overseas listing; and Chinese automobile parts included in U.S. import detention over Xinjiang concerns
Biden's new Executive Order simplifies the proposed "Reverse CFIUS" review process of outbound investment into China; Small hedge funds in China are threatened with a minimum asset requirement; and Shanghai Stock Exchange further scrutinizes medical companies as an anti-corruption campaign intensifies.
China's securities watchdog instruct lawyers to tone down China-related risk disclosures in prospectuses; new rules restrict export of drones and related technologies; and bubble tea companies seek foreign listings amidst growing regulatory scrutiny
U.S. senators propose amendment to defense bill requiring the tracking of U.S. investments in China; Foreign firms are accelerating their push to decouple their data in China from the rest of the world; and China's commerce minister pledges to open up more opportunities to foreign pharmaceutical firms in a roundtable meeting
Edward Tung, legal counsel for Hong Kong-based venture capital firm ORI Capital, discusses his firm's response to U.S. sanctions on Chinese companies, U.S. restrictions targeting foreign companies, artificial intelligence laws in China, and new ESG guidelines.
